Replies to post #16502 on The Rising Influence of Rising Affluence

[DewDiligence]

ABT 1Q18 sales by business segment:

 Medical devices  37% (+5% YoY in const currency)  
 Diagnostics      25% (+6% YoY in const currency)  
 Nutrition        24% (+5% YoY in const currency) 
 Pharmaceuticals† 14% (+7% YoY in const currency)

64% of overall sales were ex-US.

†Ex-US branded generics.

[DewDiligence]

PFE’s 1Q18 sales in China increased 26% YoY in constant currency; in emerging markets overall, sales increased 12% YoY.

PFE participates (to a lesser degree than ABT) in the branded-generics business in emerging markets.